Stockscreener 앱 받기
0.5117
4.37%
-0.0234
Heartbeam Inc 주식(BEAT)의 최신 뉴스
Form 4 Heartbeam Inc For: 25 July By Investing.com - Investing.com South Africa
HeartBeam (NASDAQ: BEAT) CTO receives 105,740 shares in bonus grant - Stock Titan
HeartBeam, Inc. (BEAT) awards 167,760 RSUs to CFO as 2025 bonus - Stock Titan
HeartBeam, Inc. (BEAT) Grants 2,800,000 PRSUs and RSUs to President - Stock Titan
Heartbeam, Inc. (BEAT) Q3 2022 Earnings ReportResults, Call & Slides - TipRanks
Heartbeam, Inc. (BEAT) Q4 2023 Earnings ReportResults, Call & Slides - TipRanks
Heartbeam, Inc. (BEAT) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
Heartbeam, Inc. (BEAT) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
Healthcare IT is the Next AI Growth Story: 3 Stocks to Buy Now - The Globe and Mail
Stock Ratings | HC Wainwright lowered its price target for NervGen Pharma (NGEN) to $15, with a potential upside of 762.07%; KeyBanc raised its price target for Nvidia (NVDA) to $330 - Sahm
BEAT Initiated Coverage by Maxim Group -- Price Target Announced at $2.00 - GuruFocus
HeartBeam receives patent for multi-modal cardiac sensing device - Investing.com UK
HeartBeam receives patent for multi-modal cardiac sensing device By Investing.com - Investing.com Nigeria
HeartBeam Awarded New U.S. Patent Expanding Acoustic Sensing and Fluid Monitoring Capabilities of Its Cable-Free ECG Device - Business Wire
Heartbeam Inc. (BEAT) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Heartbeam Inc. Warrant (BEATW) Surges 16.61% as Penny Stock Tests Key LevelEarnings Sentiment - dars.gov.et
HeartBeam (BEAT) upgraded to buy: Here's what you should know - MSN
HeartBeam Receives Nasdaq Notice on Minimum Bid Price - TipRanks
HeartBeam Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Nasdaq warns HeartBeam (NASDAQ: BEAT) over $1 minimum bid price rule - Stock Titan
Heartbeam, Inc. Warrant 2021-31.10.26 on HeartBeam Financial Disclosures & SEC Filings - TradingView
Heartbeam Inc. Warrant (BEATW) Edges Higher at $0.03 Amid Narrow Trading RangeDynamic Hedging - dars.gov.et
Heartbeam Inc. (BEAT) Dips 2.8% as Shares Test Near Support LevelsProfitability Factor - dars.gov.et
HeartBeam (BEAT) Advances Modern Cardiac Care, Expanding Use of ECG Data Outside of the Hospital - Yahoo Finance
HeartBeam Completes Enrollment in Heart Attack Detection Pilot Study Ahead of Schedule - Business Wire
HeartBeam (NASDAQ: BEAT) Advances Modern Cardiac Care, Expanding Use of ECG Data Outside of the Hospital - TradingView
Heartbeam Inc. (BEAT) Q1 2026 Earnings: EPS Beat on Narrower Loss, Pre-Revenue Stage RemainsConsensus Miss Rate - dars.gov.et
HeartBeam (BEAT) Completes Enrollment Ahead of Schedule in Heart Attack Detection Pilot Study - NewMediaWire
HeartBeam (NASDAQ: BEAT) Completes Enrollment Ahead of Schedule in Heart Attack Detection Pilot Study - USA Today
HeartBeam (BEAT) FDA Approvals, PDUFA Dates & Drug Alerts 2026 $BEAT - MarketBeat
HeartBeam Completes Enrollment in Heart Attack Detection Pilot Study - marketscreener.com
HeartBeam completes enrollment in heart attack detection study - Investing.com
Heartbeam Inc. (BEAT) Q1 2026 Earnings: EPS Surprise Beats Estimates, Stock Declines on Lack of Revenue DetailsProfit Warning Alert - dars.gov.et
HeartBeam (BEAT) Completes Enrollment in Heart Attack Detection Study Ahead of Schedule - GuruFocus
HeartBeam completes enrollment in heart attack detection study By Investing.com - Investing.com Nigeria
Heartbeam Inc. (BEAT) Slips 3.8% as Shares Test Key Support LevelsBeta Neutral Pair - dars.gov.et
Certain Restricted Stock Units of HeartBeam, Inc. are subject to a Lock-Up Agreement Ending on 29-JUN-2026. - marketscreener.com
Certain Warrants of HeartBeam, Inc. are subject to a Lock-Up Agreement Ending on 29-JUN-2026. - marketscreener.com
BEATW Warrants Hold at $0.03: Stalemate Persists for Heartbeam Inc. WarrantsInvestment Factor - dars.gov.et
HeartBeam (BEAT) Stock Sees Fair Value Cut As Analysts Weigh Dilution And Slower Ramp - Yahoo Finance
Price to book forward of Heartbeam, Inc. – NASDAQ:BEAT - TradingView
Enterprise value to revenue forward of Heartbeam, Inc. – NASDAQ:BEAT - TradingView
Price to sales forward of Heartbeam, Inc. – NASDAQ:BEAT - TradingView
HeartBeam (BEAT) Reorganizes to Accelerate Global Commercialization Strategy - NewMediaWire
HeartBeam Reorganizes to Accelerate Global Commercialization of Cardiac Monitoring Technology - MEXC
HeartBeam (NASDAQ: BEAT) Reorganizes to Accelerate Global Commercialization Strategy - TradingView
HeartBeam, Inc. Actuals & Estimates (NASDAQ:BEAT) - TradingView
BEAT Forecast — Price Target — Prediction for 2027 - TradingView
HeartBeam CEO Robert Eno to Step Down; Founder Branislav Vajdic to Lead Operations - Moomoo
HeartBeam Announces Strategic Shift to Accelerate Global Adoption of its Ambulatory ECG Signal Platform and Leadership Transition - 01net
HeartBeam restructures to license 3D ECG technology - TipRanks
HeartBeam Announces Strategic Shift to Accelerate Global Adoption - The National Law Review
Heartbeam Former CEO Robert Eno Will Transition to Consulting Role >BEAT - Moomoo
Leadership shakeup as HeartBeam (NASDAQ: BEAT) reorganizes for global ECG push - Stock Titan
HeartbeamAdvancing Toward Heart Attack Det - Moomoo
Heartbeam Announces Strategic Shift to Accele - Moomoo
Heartbeam Inc (BEAT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
1.99%
2.12%
자본화:
|
볼륨(24시간):